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PDGFRa demarcates the cardiogenic clonogenic
Sca1þ stem/progenitor cell in adult murine
myocardium
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Cardiac progenitor/stem cells in adult hearts represent an attractive therapeutic target for
heart regeneration, though (inter)-relationships among reported cells remain obscure. Using
single-cell qRT–PCR and clonal analyses, here we deﬁne four subpopulations of cardiac
progenitor/stem cells in adult mouse myocardium all sharing stem cell antigen-1 (Sca1),
based on side population (SP) phenotype, PECAM-1 (CD31) and platelet-derived growth
factor receptor-a (PDGFRa) expression. SP status predicts clonogenicity and cardiogenic
gene expression (Gata4/6, Hand2 and Tbx5/20), properties segregating more speciﬁcally to
PDGFRaþ cells. Clonal progeny of single Sca1þ SP cells show cardiomyocyte, endothelial and
smooth muscle lineage potential after cardiac grafting, augmenting cardiac function although
durable engraftment is rare. PDGFRa cells are characterized by Kdr/Flk1, Cdh5, CD31 and
lack of clonogenicity. PDGFRaþ/CD31 cells derive from cells formerly expressing Mesp1,
Nkx2-5, Isl1, Gata5 and Wt1, distinct from PDGFRa/CD31þ cells (Gata5 low; Flk1 and Tie2
high). Thus, PDGFRa demarcates the clonogenic cardiogenic Sca1þ stem/progenitor cell.
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F
ate-mapping studies provide evidence that adult mammalian
cardiac regeneration exists, though at a level insufﬁcient to
rescue damaged hearts, occurring at least partly through a
lineage decision by progenitor/stem cells1–4, not proliferation of
pre-formed myocytes as in zebraﬁsh or newborn mice5,6. This
view is supported by evidence using transgenic ﬂuorescent anillin,
that cardiomyocytes in damaged adult hearts increase in ploidy
but do not divide7. Characterizing the dormant adult cardiac
progenitors is arguably still in its infancy, despite identiﬁers
including the orphan receptor stem cell antigen-1 (Sca1;
refs 2,3,8,9), c-kit4,10, side population (SP) dye-efﬂux
phenotype11–13, Isl1 (ref. 14), cardiosphere-15 and colony-
forming assays16, aldehyde dehydrogenase17, or re-expression of
the embryonic epicardial marker Wt1 (ref. 18). Notwithstanding
these uncertainties, cardiac progenitor/stem cells have begun to
be used in human trials19. Unlike cells from bone marrow,
intrinsic progenitor/stem cells residing in the heart are
predisposed to convert to the cardiac muscle lineage after
grafting5 and are, uniquely, a possible target for activation
in situ by developmental catalysts5,18.
Existing work on endogenous cardiac progenitor cells has
chieﬂy relied on puriﬁed but potentially mixed populations.
Where clonal growth was reported, this was often achieved at a
prevalence r0.1% for fresh cells, or contingent on prior
adaptation to culture10,20–24. In one study, only 0.03% of adult
cardiac Sca1þ cells proliferated beyond 14 days20. Sheets of
clonally expanded Sca1þ cells improve cardiac function after
infarction21. Sca1þ cells have cardiogenic and vascular
differentiation potential2,8,9,12, though whether their single-cell
progeny have multilineage potential is uncertain.
Tracking cell progeny with Cre recombinase suggests that
Sca1-fated cells generate cardiac muscle in situ during normal
ageing3 and that Sca1þ cells are a major source of new myocytes
after ischaemic injury2. Fate mapping with R26R-Confetti, which
labels clonal derivatives randomly with one of four ﬂuorescent
proteins25, suggests that most single Sca1 cells have limited
expansion potential and give rise to a single cell type3. Given this
rare clonogenic potential, infrequent differentiation and variable
expression of other markers8,9,12,26, Sca1þ cells, if not further
reﬁned, are presumptively heterogeneous. More remains to be
learned about the native cells’ capacity for clonal expansion and
differentiation, including what prospective markers best predict
the dual features of clonal growth plus enrichment for
cardiogenic genes.
One candidate is the SP dye-efﬂux phenotype, which
distinguishes hematopoietic stem cells with long-term self-
renewal potential27 and is mediated by ATP-binding cassette
(ABC) transport proteins associated with ‘stemness.’ SP cells are
found in developing and adult hearts8,11 and have greater colony-
forming activity in methylcellulose than non-SP cells12, yet little
information exists for cardiac SP single-cell derivatives.
A predictor of the cardiac colony-forming units (cCFU-F) amid
adult Sca1þ cells is platelet-derived growth factor receptor-a
(PDGFRa); these multipotent cells resemble other mesenchymal
stem cells (MSCs) and originate from the epicardium16. Relative
to MSCs from other tissues, cCFU-Fs express greater Mef2c, but
lack most cardiogenic transcription factors26.
In short, there is insufﬁcient detailed information about the
molecular characteristics of progenitor/stem cells residing in the
adult heart, whether cloned cardiac cells faithfully resemble their
in situ precursors and whether they resemble the multipotent
cardiovascular progenitors in embryos and differentiating
embryonic stem cells (ESCs). Despite the need to deﬁne more
clearly the putative reservoirs of adult cardiac cells with
differentiation potential, too little is known about how the
various reported progenitors relate to one another. In particular,
can one identify a more homogenous population at the single-cell
level?
Here we have dissected the cardiac Sca1þ cells—based on
their SP phenotype, PECAM-1 (CD31) and PDGFRa—using
single-cell expression proﬁles and rigorous clonal analysis.
SP status predicted clonogenicity plus the cardiogenic signature.
However, both properties map even more selectively to
PDGFRaþ cells.
Results
A cardiogenic signature in SP cells by single-cell proﬁling. To
address the innate heterogeneity of the cardiac Sca1þ population,
single-cell qRT–PCR (PCR with quantitative reverse transcrip-
tion) was performed on fresh cells, obviating potential bias from
in vitro expansion. Given that adult cardiac Sca1þ cells are
enriched for SP cells with cardiogenic potential in vivo8,11–13, we
tested whether SP cells possess a distinguishable proﬁle. Adult
cardiac Lin /Sca1þ cells were isolated by immunomagnetic
puriﬁcation, further puriﬁed by ﬂow cytometry (Fig. 1a, left), and
stained with Hoechst 33342 (Fig. 1a, centre, right). SP cells
comprised roughly 1% of the Lin /Sca1þ population. The SP
phenotype was suppressed by reserpine and verapamil, broad-
spectrum inhibitors of ABC transport proteins, and by
fumitremorgin C, more selective for ABCG227. Gates for
preparative sorting were widely spaced and non-contiguous, to
obviate crossover by the ‘tails’ of SP and non-SP cells.
Single Lin Sca1þ cells from the total, SP and non-SP
fractions, plus single neonatal cardiomyocytes, were assayed by
qRT–PCR (Fig. 1b–d; Supplementary Fig. 1). The Sca1 gene Ly6a
was expressed in all Sca1þ , SP and non-SP cells, as predicted
from their puriﬁcation via Sca1 (Fig. 1b,c). Ly6a was not
expressed in myocytes, which had near-uniform expression of
sarcomeric genes (Myh6 and Myl2) and most cardiogenic
transcription factors (Gata4, Hand2, Mef2a/c, Nkx2-5 and
Tbx5/20); Gata6 was more rarely detected.
Among unfractionated Sca1þ cells, two complementary
patterns of expression were resolved: a major population (87%)
expressing vascular endothelial cadherin (Cdh5) and vascular
endothelial growth factor receptor 2 (Kdr), and a minor
population (13%) expressing genes for the mesodermal marker
Pdgfra and Tcf21, a transcription factor that governs epicardial
progenitor cell fate28,29. Typically, non-SP cells expressed Cdh5
and Kdr, with Mef2c and Mef2a the only prevalent cardiac
transcription factors (490% Cdh5þ /Kdrþ ; 475% Mef2cþ ).
Hence, non-SP cells (Pdgfra /Tcf21 /Cdh5þ /Kdrþ and lacking
other cardiogenic markers) resembled and likely account for the
major Sca1þ population.
The few unfractionated Sca1þ cells lacking Cdh5 and Kdr
expression were enriched instead for Pdgfra and Tcf21 and
cardiac transcription factors (Gata4, Hand2 and Tbx5/20). These
cells did not express cardiomyocyte markers, excluding myocyte
contamination as the source of this cardiogenic signature. The
Pdgfraþ /Tcf21þ /Cdh5 /Kdr phenotype was rare in non-SP
cells (11%) but predominated among SP cells (86%; Fig. 1b,c).
Gata4, Gata6, Tbx5, Tbx20 and Hand2 were most prevalent, with
little or no expression of Hand1, Isl1 and Nkx2-5, or markers of
cardiomyocytes (Myl2 and Myh6), smooth muscle (SM; Cnn1
and Myh11) and endothelium (Vwf). Thus, SP cells resemble
the minor sub-population of unfractionated Sca1þ cells. The
three Sca1þ populations expressed little or no Kit (Fig. 1c;
Supplementary Fig. 1), which may signify a coexisting cell4,10 or
precursor–product relationship.
By principal component analysis (PCA; Fig. 1d and
Supplementary Fig. 2), SP cells, non-SP cells and cardiomyocytes
were resolved as discrete groups, with the mixed Sca1þ
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Figure 1 | Single-cell proﬁles map cardiogenic gene expression to Sca1þ SP cells co-expressing Pdgfra. (a) Left, ﬂow sorting of fresh cardiac
Lin Sca1þ cells after immunomagnetic enrichment for Sca1. Center, further puriﬁcation of Lin Sca1þ cells for the SP phenotype by Hoechst 33324
staining±ABC transporter inhibitors: FTC, fumitremorgin C; Res, reserpine; Ver, verapamil. Right, bar graph, mean±s.e.m.; n¼4; *Pr0.0001.
(b) Single-cell qRT–PCR proﬁles of fresh total Sca1þ , SP and non-SP cells, compared with cardiomyocytes (CMC). The heatmap illustrates expression as
DCt values (blue, low or absent; red, high) and hierarchical clustering reveals the co-expression of functionally related genes in the populations indicated.
Highlighted are: yellow, the Sca1 gene Ly6a; blue, Kdr and Cdh5, enriched in Sca1þ and non-SP cells; red, cardiogenic transcription factors, enriched in SP
cells and CMC; green, Pdgfra and Tcf21, enriched in SP cells; violet, CMC genes. Sca1þ , n¼ 23; non-SP, n¼44; SP, n¼43; CMC, n¼ 18. For the full set of 44
genes, see Supplementary Fig. 1. (c) Density plots of expression (DCt) for selected genes in SP (light red) versus non-SP (light blue) cell populations.
Genes are ordered according to increasing P-values. Those with a signiﬁcantly divergent prevalence of expression between SP and non-SP cells are
indicated by an asterisk. (d) PCA of the single-cell expression proﬁles. (Top) PC2 (19% variability) separates SP from non-SP sample scores, whereas PC3
(9% variability) establishes a distinct separation between SP/non-SP/Sca1þ cells and CMC. Non-SP and unfractionated Sca1þ cells cluster together in the
PC projection. (Bottom) Gene loadings contributing to each PC indicate that a small subset of genes explain the cross-group variability captured by PC2
and PC3. Cdh5 and Kdr are predominantly associated with non-SP and unfractionated Sca1þ cells, while Pdgfra and Tcf21 are correlated with SP cells (as
given by PC2). Differences between CMCs and the remaining samples are strongly reﬂected in PC3, with cardiac structural genes (Myh6 and Myl2)
clustered consistently.
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population straddling its SP and non-SP fractions (Fig. 1d, upper
panel). This separation of SP cells, non-SP cells and cardiomyo-
cytes is concordant with their distinct phenotypes, and prefer-
ential clustering of Sca1þ cells with non-SP cells consistent with
the predominance of non-SP cells in the Sca1þ population.
Separation visualized by principal component (PC)2 and PC3 was
attributable to four subsets of genes, which collectively deﬁne the
main differences (Myh6,Myl2; Gata4, Hand2, Tbx20, Tbx5; Cdh5,
Kdr; Pdgfra, Tcf21; Fig. 1d, below).
For most genes, expression or its absence was homogeneous
within each respective population (Fig. 1b,c). However, cardio-
genic genes were commonly bimodal in SP cells. Considering the
functionally signiﬁcant tetrad of Gata4, Mef2c, Tbx5 and Hand2
(ref. 30), only 8 of 43 cardiac SP cells expressed all four—a
‘mosaic’ transcription factor phenotype in 480% of the cells.
Nkx2-5, Isl1 and Hand1 were not detected. Of the cardiogenic
genes identiﬁed, only Mef2a and Mef2c were expressed equiva-
lently in SP and non-SP cells, each in a bimodal pattern (Fig. 1c).
Thus, unlike cardiomyocytes, fresh single SP cells show highly
mosaic expression of key cardiogenic genes, a potential block to
their differentiation. Conversely, the existence of any cells with all
four factors yet not target gene activation suggests that these
factors do not sufﬁce at their native levels to drive differentiation,
or that other barriers exist.
Several stem cell-associated markers showed bimodal expres-
sion in SP and non-SP cells, equivalently, including ABC
transporters (Abcg2 and Abcb1) and two key genes for
pluripotency (Nanog and Pou5f1); a third, Klf4, was present in
nearly all Sca1þ cells regardless of SP status (Fig. 1c;
Supplementary Fig. 1). Thus, differences in Abcg2 and Abcb1
mRNA do not establish the dye-effux phenotype—implicating
potential differences in pump protein, activity or alternative
transporters. Pluripotency genes showed no relation to the
cardiogenic signature.
In summary, SP cells largely—but imprecisely—represent
the adult cardiac Sca1þ cells having the molecular signature
suggesting a cardiogenic phenotype. The dichotomous expression
of Pdgfra and Tcf21 versus Cdh5 and Kdr deﬁnes more exactly the
cells enriched for cardiogenic transcripts. Cardiac SP cells (more
accurately, Pdgfraþ /Sca1þ cells) express Gata4/6, Mef2a/c,
Tbx5/20 and Hand2, but rarely Hand1, Isl1 and Nkx2-5, features
of the ﬁrst, second and both heart ﬁelds, respectively. Hence,
these adult cells resemble a persistent but incomplete form of the
developing cardiac mesoderm.
Clonogenic self-renewing phenotype of cardiac Sca1þ SP cells.
To pinpoint where the rare clonogenic capacity of Lin /Sca1þ
cells resides, and allow stringent production of single-cell deri-
vatives, preparative ﬂow sorting was performed. The direct
cloning efﬁciency for single cardiac SP cells wasB1% (21 clones/
1,995 cells plated), in the absence of a feeder layer or prior
adaptation to culture, ten-fold higher than for non-SP cells,
analogous to the greater formation of colonies by SP cells in
methylcellulose12 (Fig. 2a).
Cloned cardiac SP cells were propagated for 410 months
and 300 doublings, without crisis or replicative senescence
(Fig. 2b). At passage 15–16, o5% showed senescence-associated
b-galactosidase activity; four clones were retested later, with 0.3%
of cells positive at passage 25, indicating selection against this
subpopulation (Fig. 2c). Clones even at 29 passages were highly
enriched for Sca1 and the SP phenotype (Fig. 2d) and, at 14
passages, generated secondary clones with an efﬁciency 440%
(6 primary clones tested, 1,425 cells plated; Fig. 2e,f). Thus,
cloned cardiac SP cells are self-renewing and maintain their
phenotype after long-term propagation.
Cloned cardiac SP cells maintain the cardiogenic signature. To
learn whether cloned cardiac SP cells retain the cardiogenic
transcription factors of the starting cells (Fig. 1b,c) or resemble
the cCFU-F, lacking these16,26, we analysed 420 clonal cardiac
SP lines for 440 relevant genes, using 384-well RT–PCR arrays
(Fig. 3a–d). By hierarchical clustering of the Pearson correlation
matrix, clonal cardiac SP cell lines were a contiguous entity
distinct from PDGFRaþ bone marrow MSCs, undifferentiated
ESCs, cardiomyocytes and reference tissues (Fig. 3a; Supple-
mentary Fig. 3). Results are summarized as bar plots (Fig. 3b) and
density plots depicting the prevalence of expression at each level
(Fig. 3c). Cardiogenic transcription factors were enriched (Fig. 3b;
Supplementary Fig. 3a). Expression was typically uniform across
the clones, but variable or bimodal for several (Gata4, Hand2,
Mef2c and Tbx5/20; Fig. 3c), as in fresh single SP cells (Fig. 1c).
Most common were Gata6, Mef2a and Tbx20, with Hand1, Isl1
and Nkx2-5 least frequent (Fig. 3c). All but Mef2c were greater in
cloned SP cells than in bone marrow MSCs (Supplementary
Fig. 3a). Other features included: (i) enrichment for stem cell-
associated markers (Abcg2, Abcb1b and Klf4), though not Nanog
or Pouf51; (ii) no cardiomyocyte markers (Actc1, Myl2, Nppa and
Pln); (iii) little or no expression of vascular (Cdh5, Kdr, Vwf,
Cnn1 and Myh11) and hematopoietic (Tal1) markers, excepting
Gata2; and (iv) high expression of Pdgfra.
Given the presence of Gata4, Mef2c, Tbx5, Hand2 and Nkx2-5
in the ancestral network for cardiogenesis31, their importance to
cardiogenic differentiation by ectopic transcription factors30,32,
and their heterogeneous expression in fresh cardiac SP cells, these
genes were plotted by two-dimensional clustering to visualize
more clearly their state of co-expression in clonal progeny
(Fig. 3d). Expression was highly mosaic, with permutations of 2–3
factors, but never all ﬁve simultaneously, and Nkx2-5 being rarest.
Hence, the clones recapitulate the single cells’ phenotype of
mosaic co-expression. Cardiac transcription factors were well
maintained over time, apart from loss of Tcf21 (Supplementary
Fig. 3b,c). Given the existence of rare fresh cells co-expressing
Gata4,Mef2c, Tbx5 and Hand2, but never clones, such cells might
be least clonable.
Thus, by single-cell qRT–PCR and clonal analysis, cardiac SP
cells resemble an incomplete but stable form of heart-forming
mesoderm, a transient phenotype in embryos and embryoid
bodies. What maintains their arrested development is unknown.
Possibilities include failure to express the transcription factors as
nuclear proteins. Hence, western blotting was performed on
nuclear and cytoplasmic lysates of four clones (indicated with * in
Fig. 3d). TBX20 and MEF2A were detected in all, as expected
from their mRNA expression (Fig. 3d), and were nuclear-
localized (Fig. 3e; Supplementary Fig. 4). GATA4, TBX5 and
NKX2-5 were nuclear in all clones expressing these and absent
from the remainder (Fig. 3d,e). Weak or absent expression of
Mef2c was paralleled by lack of MEF2C protein. For expressed
genes, protein expression was highly uniform (485% positive;
Supplementary Fig. 5). Thus, cloned cardiac SP cells resemble the
molecular signature of freshly isolated SP cells, and clonal
variations recapitulate the fresh cells’ microheterogeneity.
Tri-lineage cardiovascular markers develop after grafting.
Intact myocardium provides the best-agreed environment for
differentiation of cardiac progenitors into cardiomyocytes and
vascular cells8,10,13,15,16,21. To test whether cloned cardiac SP cells
maintain their differentiation capacity and ascertain with single-
cell progeny their multilineage potential, representative clones
expressing mOrange were injected into the infarct border zone
(clones 3, 5, 15 and 16). Cell retention 1 day later varied from 1 to
8%, declined to 0.1–0.5% at 2 weeks, and was no greater in
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control uninjured hearts. Retention r10% with later further loss
is consistent with other studies33.
One day after grafting, no precocious expression was seen for
seven markers of differentiation (Supplementary Fig. 6a). At
2 weeks, 10% of donor cells expressed cTnI and sarcomeric
a-actin, of which half were double stained; similar results were
obtained for myosin light chain 2v plus sarcomeric myosin heavy
chains (Fig. 4b; Supplementary Fig. 6a, b). The differentiating
mOrangeþ cells were mononucleated and lacked organized
sarcomeres, indicating immaturity.
By contrast, at 12 weeks, cTnI and sarcomeric a-actin were
expressed in up to 50% of donor-derived cells, with organized
sarcomeres and binucleation also detected (Fig. 4a,b). The
mOrangeþ cells detected histologically at this later time point
were scarce, however, and only 5–10 mOrangeþ rod-shaped cells
were recovered from each heart following enzymatic dissociation
at 12–14 weeks (Fig. 4c,d).
Endothelial markers CD31 and vWF were expressed in 4–8%
of cells beginning within 2 weeks (Fig. 4e,f; Supplementary
Fig. 6c,d), and SM-myosin heavy chains in 5–15% (Fig. 4g,h;
Supplementary Fig. 6e, f). Although not easily identiﬁable within
vascular structures after short-term grafting, donor-derived
differentiating cells were found at 12 weeks in the endothelial
and SM layers (Fig. 4e,g).
Overall, no difference was seen between injured and uninjured
hearts, or between clones, except increased SM formation after
infarction with one. Little or no staining was seen after injection
of tail tip ﬁbroblasts (Supplementary Fig. 6g).
To assess whether grafting-cloned SP cells had a functional
impact following infarction, serial magnetic resonance imaging
(MRI) measurements were performed (Fig. 5). At one day, no
differences were seen between the infarcted groups with and
without SP cells, both having similar infarct area and reduction of
ejection fraction. Notably, at 12 weeks, cell grafting preserved
ejection fraction (22±2%), compared with the vehicle-treated
control (12±1%), reduced infarct size (38±1% versus 45±2%)
and reduced the prevalence of severe left ventricle (LV)
remodelling (LVEDV 3 the control value) by 44% (P¼ 0.02
by Pearson’s w2-test).
These data using single-cell clones support the tri-lineage
potential of cardiac SP cells24, and suggest that their
‘developmental arrest’ can be overridden despite incomplete
expression of the cardiogenic programme, within the range of
factors’ represented here. Infarct size, LV function and the
prevalence of severe remodelling all were improved by cell
grafting. However, biomechanical beneﬁts under these conditions
of delivery are more plausibly due to paracrine effects
(as in related publications34,35) than to direct actions of the
infrequently persistent, newly formed mOrange-positive cardio-
myocytes.
Cardiac SP cells derive from Isl1- and Nkx2-5-expressing cells.
Potential origins of cardiac SP cells include the specialization of
primitive mesoderm denoted by Mesp1, a determinant of multi-
potent cardiovascular progenitor cells36. Like fresh adult cardiac
Sca1þ cells8, fresh single SP cells and clones typically lack Nkx2-5
and Isl1 (Figs 1 and 3; Supplementary Figs. 1,3) yet could be the
progeny of cells expressing these formerly, that is, after
speciﬁcation by Mesp1. To evaluate these and other possibilities,
we performed Cre/lox fate mapping, converting antecedent
expression of Cre recombinase into persistent activation of a
sensitive reporter, the Ai14 form of Rosa26-tdTomato (tdTom)37.
The ﬁdelity of each bigenic line (Supplementary Table 3) was
conﬁrmed by induction of tdTom (Fig. 6a) and contributions to
cardiac Lin /Sca1þ /SP cells were quantitated by ﬂow cytometry
(Fig. 6b,c). Cre driven by the viral EIIa promoter evoked
ubiquitous tdTom. Without Cre, no recombination occurred.
With Mesp1-Cre, most cardiac cells expressed tdTom, including
myocytes, vessels and interstitial cells. Virtually all Lin /Sca1þ
cells derived from Mesp1þ precursors, whether SP or not,
suggesting an origin from pre-cardiac mesoderm. Neither SP nor
non-SP cells were derived from neural crest, hematopoietic cells
or pre-existing cardiomyocytes, deﬁned using Wnt1-, Vav- and
Myh6-Cre.
Day 1 Day 7 Day 14
1.5
0.0
0.5
1.0
Cl
on
es
 (%
) *
SP
0
*
FSC
Sc
a-
1-
FI
TC 0.41%11%99%
Hoechst red
H
oe
ch
st
 b
lu
e
+ FTCSP
Cl
on
es
 (%
)
Pri
ma
ry
Se
con
da
ry
Days
400
0
200
300
100
Clone 3
Clone 5
Clone 16
Clone 15
Po
pu
la
tio
n 
do
ub
lin
gs
4000 200 300100 500
Passage
*
2.0
**
Non-SP
 
SA
-β-
ga
l+  
ce
lls
 (%
)
0.0
0.5
1.0
1.5
15
–1
6 25
33
–4
2
60
40
20
Figure 2 | The Sca1þ SP phenotype identiﬁes clonogenic, self-renewing cardiac cells. (a) Bar graph showing the % of adult cardiac clone-forming cells
from Lin Sca1þ SP and non-SP fractions, after single-cell deposition. n¼ 7; *Pr0.02. (b) Long-term growth of cloned cardiac SP cells. Clones shown are
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SP clones after long-term culture. Results shown here (clone 16 at passage 29) were conﬁrmed in four additional clones. (e,f) Enrichment for 2 clone
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100mm. (f) 2 clone formation by six independent clones at passage 13–14. *Pr0.005. Data are shown as the mean±s.e.m. between independent
experiments.
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Figure 3 | Fidelity of cloned cardiac SP cells to freshly isolated SP cells (a) Pearson correlation plot, each cell of the heatmap showing the sample pair’s
correlation coefﬁcient (r). The clustering algorithm separates highly correlated samples (red: r close to 1) from weakly correlated ones (blue: r close to 0).
The 20 independent lines of cloned cardiac SP cells show strong within-group correlation, moderate correlation to MSCs and ESCs, and weak correlation to
other samples including heart. All clones were analysed ato30 passages. BM, bone marrow; CM, neonatal cardiomyocytes; eH, embryonic day 10 heart;
ESC, undifferentiated AB2.2 ESCs; H, adult heart (encompassing whole heart, atria, and each ventricle); K, kidney; L, liver; MSC, PDGRaþ bone marrow
MSCs; Sk, skeletal muscle; Sp, spleen. (b) Molecular signature of cloned cardiac SP cells. Bar graph, mean±s.e.m. for all 40 genes’ expression in
20 independent clones. Genes are colour coded based on functional association or tissue speciﬁcity. For comparison with reference samples, see
Supplementary Fig. 3. (c) Density plot showing the prevalence for expression of key cardiac transcription factors in the 20 clones. See Fig. 1d. The clustering
algorithm separates genes with heterogeneous (multimodal) expression from those with homogeneous low or high expression. (d) Heatmap showing
scaled expression of the four most heterogeneous transcription factors in the 20 clones (Gata4, Mef2c, Tbx5, Hand2 and Nkx2-5). Expression within each
sample is scaled to Z-score, 0 indicating mean expression of the four genes. Red indicates higher expression than the mean, while blue indicates lower
expression. The two-dimensional hierarchical clustering algorithm orders the clones and genes based on co-expression proﬁles. Asterisks denote four
clones taken forward to more detailed studies. (e) Western blots for cardiac transcription factors in the clonal lines. Cytoplasmic (C) and nuclear (N)
fractions were analysed using glyceraldehyde 3-phosphate dehydrogenase and histone H1 to authenticate the fractions and b-actin as a loading control.
The bands for TBX20 correspond to isoforms with or without the C-terminal 145 a.a. extension.
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Nkx2-5þ precursors generate most cardiomyocytes in the
heart, plus endothelium and SM; Isl1þ progenitors give rise
chieﬂy to the right ventricle, outﬂow tract and atria (from the
second heart ﬁeld), contributing less to the left ventricle (from the
ﬁrst heart ﬁeld)38. In all chambers, as expected, most cells were
Nkx2-5-fated (Fig. 6a). Left ventricular labelling was patchy
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Figure 4 | Cloned cardiac SP cells show tri-lineage potential after cardiac grafting. Clones were transduced with mOrange and delivered by intramural
injection into mice subjected to sham operation (control) or coronary artery ligation (infarction). (a) Co-expression of cardiac troponin I (cTnI, green) and
sarcomeric a-actin (sarc actin, violet) in striated grafted cells at 12 weeks. (b) Bar graph showing the proportion of mOrangeþ cells expressing sarcomeric
proteins at 2 or 12 weeks. (c,d) Cardiomyocyte isolation was performed on hearts injected with mOrangeþ cloned cardiac SP cells at the time of infarction
12–14 weeks earlier. mOrangeþ rod-shaped cardiomyocyte-like cells were detected in the preparations. (c) Representative cells from three independent
hearts are shown. Scale bar, 100mm. (d) Representative cells co-stained for mOrangeþ and sarcomeric a-actin. Control, secondary antibody only. Scale
bar, 20mm. (e) Induction of von Willebrand factor (vWF, green) and localization of mOrangeþ cells in vessels at 12 weeks. (f) Bar graph showing the
proportion of mOrangeþ cells expressing vWF at 2 weeks. (g) Induction of SM-myosin heavy chain (SM-MyHC, green) and localization of mOrangeþ
cells in vessels at 12 weeks. (h) Bar graph showing the proportion of mOrangeþ cells expressing vWF at 2 weeks. At least 200 cells were scored for each
clone for each condition, using at least three sectionsZ80mm apart containing mOrangeþ cells. Data for each clone and time point are the mean±s.e.m.
for 3–4 control hearts and 5–7 infarcted ones. Immunohistochemistry is shown here for two clones at 12 weeks and for all four clones at 2 weeks in
Supplementary Fig. 4.
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with Isl1-Cre, whereas second heart ﬁeld derivatives labelled
uniformly. By ﬂow cytometry, more than half the Lin /Sca1þ
cells were Nkx2-5-derived—ﬁvefold more than for cCFU-Fs16—
with an equal contribution from Isl1-fated cells (Fig. 6b,c). Less
than 20% of SP and non-SP cells were fated by anterior heart
ﬁeld-restricted Mef2c-AHF-Cre. Whereas Nkx2-5 and Isl1 were
expressed rarely in fresh single cells and cloned cardiac SP cells
(Figs 1 and 3), their large contribution to the fate map suggests an
origin from cardiac mesoderm, involving both heart ﬁelds or just
the second. Alternatively, as Nkx2-5 and Isl1 contribute to the
pro-epicardial organ39, a pro-epicardial origin is possible. Indeed,
50% of cardiac SP cells were labelled by proepicardium-expressed
cGATA5-Cre (Fig. 6b,c), albeit less than in cCFU-Fs16.
By contrast, non-SP cells showed greater contributions from
Flk1- and Tie2-Cre, consistent with their endothelial lineage
markers Cdh5 and Kdr.
Given that differences between cardiogenic and endothelial
lineage genes in SP and non-SP cells mapped to the Pdgfraþ and
Cdh5þ /Kdrþ phenotypes, respectively, we reﬁned the Cre/lox
analysis, adding antibodies against PDGFRa and the endothelial
lineage marker CD31. SP and non-SP cells were each divided
into two subpopulations, PDGFRaþ /CD31 and PDGFRa /
CD31þ (Fig. 7). These two features can be mutually
exclusive16,40 or partially overlapping (Fig. 7a; cf. Fig. 8a),
hence their combined use for prospective sorting is more
stringent than PDGFRa alone. Regardless of the SP phenotype,
B90% of PDGFRa /CD31þ cells were labelled by Flk1-Cre,
unsurprising given this fraction’s expression of Flk1/Kdr. By
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Figure 5 | Intramyocardial delivery of cloned cardiac SP cells improves cardiac structure and function. Views by cine-MRI are shown at end-diastole and
end-systole, along with late Gadolinium (Gd)-enhanced MRI (LGE) for infarct size. (a) Representative images of mouse hearts at 1 day and 12 weeks after
infarction (MI) and grafting of clones. The red bar highlights end-systolic and end-diastolic diameters. (b) Serial measurements showing improved ejection
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Figure 6 | Sca1þ SP cells derive from Mesp1-, Nkx2-5-, Isl1-, Gata5- and Wt1-fated cells. (a) Cre drivers were crossed with the Ai14 R26R-tdTom line.
Left, longitudinal sections of the heart at low magniﬁcation. Right, ventricular myocardium and brain at high magniﬁcation. Orange, Cre-dependent
expression of tdTom; blue, 40,6-diamidino-2-phenylindole. Scale bar, 1mm (left), 25mm (right). (b,c) Quantitation of cardiac SP and non-SP cells derived
from the Creþ ancestors shown. (b) Left, ﬂow cytometry showing no interference of Cre with SP cell number. Right, tdTom in the SP and non-SP fractions
of Lin/Sca1þ cells. (c) Bar graph, % tdTomþ cells; n¼ 3–8; *Pr0.05; **Pr0.001. Data are shown as the mean±s.e.m. for independent experiments.
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comparison, Flk1-Cre and Tie2-Cre contributed little to the
PDGFRaþ /CD31 SP and non-SP cells (10–20%).
Conversely, PDGFRaþ /CD31 cells were highly labelled by
cGata5-Cre and by activating Wt1-CreERT2 with tamoxifen at
E10.5 (70–80% and 40–60%, respectively). Tamoxifen at 8 weeks
labelled none of the four Sca1þ populations. PDGFRa /CD31þ
cells were infrequently labelled by cGata5-Cre (10%), with no
contribution from embryonic activation of Wt1-CreERT2; this
may reﬂect lesser sensitivity of CreERT2, especially at permissible
doses of tamoxifen. Small differences were seen using Nkx2.5-
and Isl1-Cre: 60–70% of PDGFRaþ /CD31 cells versus 40–50%
of PDGFRa /CD31þ ones.
These results are summarized in Fig. 7c, integrated with
relevant aspects of cardiac origins during embryogenesis and ESC
differentiation41–46. Virtually all cardiac Sca1þ cells, whether SP
or non-SP, PDGFRaþ or CD31þ , derive from Mesp1þ
mesoderm. Flk1þ multipotent progenitors (likely co-expressing
PDGFRa46,47) have potential to differentiate into cardiovascular
lineages including cardiomyocytes, endothelial and SM cells.
Adult PDGFRaþ /CD31 and PDGFRa /CD31þ cells derive
largely from Nkx2-5þ and Isl1þ precursors—with known
cardiovascular tri-lineage potential14—genes whose contribution
here concurs with their role in proepicardium development38,
upstream of Gata5 and Wt1 (ref. 39). Incomplete labelling of
PDGFRaþ cells by Flk1-Cre is likely due to lower or transient
expression of Flk1 relative to CD31þ cells48. That cardiac
CD31þ cells were only rarely labelled by cGATA5-Cre and
Wt1-CreERT2 agrees with evidence that coronary endothelium
derives from a Wt1 precursor49. These divergent, antithetical
subpopulations expressing PDGFRa (and cardiogenic genes)
versus CD31 (and endothelial genes) associate imprecisely with
SP status.
PDGFRa tracks speciﬁcally with the cardiogenic signature.
Given that fresh Lin /Sca1þ /SP cells and their clonal derivatives
are enriched for Pdgfra, and that Sca1 and PDGFRa are attributes
of MSC-like cardiac progenitors identiﬁed by the CFU-F assay16,
PDGFRa and MSC markers were analysed by ﬂuorescence-
activated cell sorting (FACS; Supplementary Fig. 7). CD105 and
CD90 were expressed in Z70% of fresh cardiac SP cells and
equally in non-SP cells. CD73, CD44 and PDGFRa were detected
in just 20–40% of fresh cardiac SP cells, but two- to three-fold
more often than in non-SP cells. Greater labelling for PDGFRa
concurs with SP cells’ greater expression of Pdgfra.
Consequently, we performed four-way preparative sorting
much as done for Fig. 7: cardiac Lin /Sca1þ cells were
partitioned on the basis of SP versus non-SP phenotype, plus
PDGFRaþ /CD31 versus PDGFRa /CD31þ (Fig. 8a). The
latter two dichotomous groups constituted485–90% of the cells,
with few double-positive or -negative cells. The yield by this
approach was B2,400,000 Sca1þ cells/heart, with 10,000
PDGFRaþ /CD31 cells from the SP fraction and 90,000 from
the non-SP fraction. (Although comprising a small minority of
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Figure 7 | cGata5 and Wt1 contribute speciﬁcally to PDGFRaþ/CD31 cells. (a) Flow cytometry illustrating the four-way strategy to dissect fate
mapping in cardiac Lin/Sca1þ cells by SP staining plus PDGFRa and CD31. Representative results are shown at the right for strong induction of tdTom in
all four populations by antecedent expression of Nkx2-5-Cre. (b) Precursors expressing cGata5 andWt1 give rise to the PDGFRaþ/CD31 cells. Little or no
difference was seen between SP and non-SP cells having the same PDGFRa/CD31 phenotype. Data are the mean±s.e.m. for tdTom induction by each Cre
line in the four populations; n¼ 2–7 excepting n ¼ 1 for Tie2-Cre; *Po0.05; **Po0.01; ***Po0.001. (c) Schematic representation of the origin of cardiac
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expression as DCt values (blue, low; red, high). Genes are ordered based on the variance of mean expression levels of the four groups. Highlighted genes:
green, Cdh5 and Kdr, enriched in PDGFRa/CD31þ cells; light red, Pdgfra, Tcf21, Tbx20, Gata4 and Hand2, in PDGFRaþ/CD31 cells; yellow: Ly6a, in all
four subpopulations. n¼ 60–70 for each. (d) Left, gating strategy to identify mutually exclusive PDGFRaþ and CD31þ cells within the Sca1þ population.
Right, bar graph showing the % of cells from the indicated populations. Mean±s.e.m.; n¼ 5; *Po0.0001. (e) Density plots show DCt values of the
indicated genes in single PDGFRaþ/CD31 (light red) and PDGFRa/CD31þ (light blue) cells from the three sample groups (SP, non-SP and Sca1þ ).
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loadings associated with PC1 and PC2. Genes associated with PC1 are unrelated to cell class: consistently absent/low expression across all samples at the
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CD31þ cells, at the top, with Pdgfra, Tcf21 and cardiac transcription factors, prevalent in PDGFRaþ/CD31 cells, at the bottom.
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the non-SP cells, PDGFRaþ /CD31 non-SP cells outnumber
the PDGFRaþ /CD31 SP cells, given the much rarer SP
phenotype.)
PDGFRa and the SP phenotype synergize for clonal growth.
Next, the relative importance of PDGFRa, CD31 and the SP
phenotype was compared in clonogenicity assays. Using ‘phy-
siological hypoxia’ to lessen hyperoxic stress and enhance clone
formation50, the SP phenotype was dispensable for direct cell
cloning (2.2±0.7% in PDGFRaþ /CD31 /non-SP cells; 0±0%
in PDGFRa /CD31þ /non-SP cells) but highly synergistic with
the PDGFRa/CD31 phenotype (28.5±3.2% in PDGFRaþ /
CD31 /SP cells; 0.3±0.3% in PDGFRaB/CD31þ /SP cells;
Fig. 8b). Proportionally similar differences were seen in
normoxia, at lower rates of clone formation (12.6±1.3% in
PDGFRaþ /CD31 /SP cells; 0.5± 0% in PDGFRaB/CD31þ /SP
cells; 1.6±0.96% in PDGFRaþ /CD31 /non-SP cells; 0% in
PDGFRa /CD31þ /non-SP cells).
Single-cell qRT–PCR as in Fig. 1 was performed on 60–70 cells
from each of the four freshly sorted populations (Fig. 8c). Gata4,
Mef2c, Hand2 and Tbx5/20 were enriched in PDGFRaþ /CD31
cells regardless of their SP status (all cells Ly6aþ /Pdgfraþ /
Tcf21þ ). Conversely, Cdh5 and Kdr were expressed in both
PDGFRa /CD31þ fractions (all cells Ly6aþ /Pdgfra /Tcf21 ).
Thus, single-cell proﬁles deﬁne two mutually exclusive subpopu-
lations: one expressing Pdgfra, Tcf21 and cardiac transcription
factors (the phenotype of cloned cardiac SP cells), Pdgfra cells
lacking these and having vascular markers instead.
Prospective sorting of cardiogenic cells using PDGFRa.
Because the SP phenotype was dispensable for clonogenicity and
requires a mutagenic dye that is unsuited to translation, we tested
the alternative that separating Lin /Sca1þ cells based on
PDGFRaþ /CD31 (omitting Hoechst 33342) would pro-
spectively purify cells with a consistent cardiogenic signature
(Fig. 8d–f). The single-cell proﬁles of all six populations—the
PDGFRaþ /CD31 versus PDGFRa /CD31þ subsets of
Sca1þ , SP and non-SP cells respectively—were compared with
PCA (Fig. 8e). PDGFRaþ and PDGFRa populations were
separated clearly, attributable to antithetical expression of Pdgfra/
Tcf21 versus Cdh5/Kdr, the former genes co-segregating with
Gata4/6, Hand2, and Tbx5/20. Density histograms showed
equivalent impact of PDGFRa on gene expression regardless of
SP status (Fig. 8f). The ‘hinge’ population between the rigorous
SP and non-SP gates also was enriched for PDGFRaþ /CD31
cells, and cardiogenic gene expression here likewise tracked with
PDGFRa (Supplementary Fig. 8). Conversely, gene enrichment
in PDGFRa /CD31þ cells included Tal1 and Gata2, heman-
gioblast transcription factors that, respectively, repress the cardiac
fate and assist the binding of Tal151.
Given the cardiogenic gene proﬁle of PDGFRaþ /CD31 cells
across all the various Sca1þ populations, we sought to test
whether PDGFRa and CD31 might sufﬁce for prospective sorting
of cells capable of cardiac differentiation in vivo, as reported
for CD31 SP cells if co-cultured with cardiomyocytes12.
PDGFRaþ /CD31 Sca1þ cells were puriﬁed as in Fig. 7d,
expanded for r10 passages as was essential to produce a
sufﬁcient number for injection, and were then delivered to
recipient hearts, with and without infarction. In both settings,
engraftment and co-expression of a-sarcomeric actin were
conﬁrmed at 2 weeks (Supplementary Fig. 9). The reciprocal
PDGFRa /CD31þ population could not be tested under
comparable conditions, however, as these do not undergo
equivalent expansion.
Discussion
For a decade, investigations of adult cardiac progenitor/stem
cells have proposed diverse criteria to deﬁne and purify these
cells and, recently, progress them into human trials of cardiac
repair19. The relationships among reported cardiac progenitor
cells remain frustratingly elusive, even among various
Sca1þ cells. By microarray proﬁling of cardiac Sca1þ , SP and
c-kitþ cells, Sca1þ cells were closest to cardiomyocytes in their
transcriptome-wide molecular phenotype and c-kit cells most
remote52. Gaps in the present understanding of cardiac stem/
progenitor cells may largely arise from molecular heterogeneities
that can be unmasked using single-cell expression proﬁles as a
guide. Such evidence would be essential to develop a dendrogram
relating the potential cardiogenic reservoirs in adult myocardium.
Here we combined single-cell qRT–PCR proﬁling with
preparative ﬂow sorting, single-cell deposition, clonogenic assays
and systematic investigation of the resultant clones to pinpoint
Sca1þ cells that were enriched for the attributes of a cardiac stem
cell. We speciﬁcally link Pdgfra with the cardiogenic signature of
Gata, Hand and Tbx genes, features mutually exclusive with the
endothelial markers Cdh5 and Kdr in Pdgfra cells. This relation
in turn led us to the PDGFRaþ /SP cell as remarkably enriched
for the cardiogenic gene signature and clonogenicity, the latter
being not only just an attribute of ‘stemness’ but also
instrumental to prove multilineage potential after grafting.
Our results provide clarity into the intricate relationships
among at least those cardiac progenitor cells with Sca1 in
common, unmasking subpopulations and microheterogeneities
previously unknown: (i) fresh single SP cells express the
pluripotency markers Nanog, Oct4 and Klf4, in concert with
cardiac transcription factors; (ii) their cardiogenic signature is
incomplete, resembling a forme fruste of cardiogenic mesoderm
during embryogenesis; (iii) cardiac SP cells are highly enriched
for Pdgfra mRNA and protein; (iv) Pdgfra and PDGFRa
demarcate the cells expressing cardiac transcription factors with
greater sensitivity and precision than does the SP phenotype;
(v) the inverse correlation between cardiac and endothelial
lineage genes suggests a mechanistic basis for differences in SP
cells expressing or lacking CD3112; (vi) clonal progeny faithfully
recapitulate the cardiogenic signature of the starting SP cells,
including mosaic expression of Gata, Hand and Tbx factors; and
(vii) PDGFRa is sufﬁcient to deﬁne clonogenic cells prospectively,
with ten-fold synergy for clonal growth in cells also possessing the
SP phenotype. In physiological O2, the direct cloning efﬁciency of
fresh single PDGFRaþ /SP cells was425%.
The consensus signature of cardiac PDGFRaþ /Sca1þ cells is
the presence of Gata4/6, Mef2a/c, Tbx5/20 and Hand2, genes
essential for normal cardiogenesis31,53 and encompassing four
(Gata4, Mef2c, Tbx5 and Hand2) whose supraphysiological
expression drives ﬁbroblasts to a cardiomyocyte-like
phenotype30. Fresh single SP cells, like single clones, chieﬂy
express just 2–3 of these, unsuspected heterogeneity we unmasked
by single-cell proﬁling. Conceivably, such mosaicism might
function to restrain precocious differentiation and exhaustion of
the stem cell pool. While the existence of even a few cells co-
expressing all four factors without their targets might seem
paradoxical, it would be misleading to assume that the four sufﬁce
for cardiogenesis at native levels. Our results do not exclude
heterogeneity in genes not measured, or epigenetic and post-
translational impediments.
The cardiac SP cell produced by preparative cell sorting
partially resembles the cCFU-F produced by colony formation
(sharing clonogenicity, multilineage potential, co-expression of
PDGFRa with Sca1), but also differs signiﬁcantly, as the cCFU-F
lacks enrichment for the cardiogenic genes emphasized here16,26.
This may reﬂect differences in cell selection, if the colony-forming
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assay discerns or elicits a more primitive cell. Most aspects of the
fate map were similar, both derived from mesodermal cells
expressing Mesp1, and at least in part from the pro-epicardial
organ based on cGata5 and Wt1. Innately, Cre-lox fate-mapping
can deﬁne only the minimal derivation from precursors
expressing a given gene, contingent on the duration and level
of Cre expression and on reporter gene functionality in a given
context39. The few fate-mapping differences between freshly
isolated cardiac PDGFRaþ /Sca1þ cells and the cultured
cCFU-F—chieﬂy, greater derivation from Nkx2-5þ cells—are
quantitative, not qualitative. Biological distinctions are possible,
consistent with the gene proﬁles, but technical differences in
recombination are an alternative and perhaps more parsimonious
interpretation. As fate mapping does not exclude dual origins
from the cardiac crescent and pro-epicardial organ, it would be
intriguing to compare further the Nkx2-5- and Wt1-fated cells.
Notably, the SP phenotype was largely but incompletely
speciﬁc as a predictor of cardiogenic gene expression in single
cells, whereas Pdgfra co-segregated with cardiac transcription
factors with absolute precision. Tcf21, a feature of cardiac SP
cells11, was strictly co-expressed in the Pdgfraþ /PDGFRaþ cells
enriched for heart-forming factors. Tcf21-fated cells contribute
to the epicardium, coronary vessels and interstitium of the adult
heart54. It is unknown whether Pdgfra and Tcf21 function in
adult cardiac Sca1þ cells’ clonal growth and cardiovascular
differentiation. Assuming a human counterpart exists for
Sca1þ /PDGFRaþ cells, we speculate that PDGFR may be
useful towards obtaining cardiogenic cells from adult human
hearts without need for the mutagen Hoecsht 33342 or selection
in culture. PDGFRaþ progenitor cells exist in human hearts,
whose capacity for cardiac differentiation is not settled17,40, and
supplemental markers may be required. At the least, PDGFRa
provides a rational means, in mice, to purify fresh adult cardiac
cells that are uniformly enriched for cardiogenic genes, in greater
yield and homogeneity than achievable with SP cells, as an
enhanced platform for ‘omic’ studies and the search for
developmental catalysts.
Methods
All animal procedures were performed under UK Home Ofﬁce approval
(PL 70/6806, 70/7880).
Cell isolation and ﬂow sorting. Adult male 8- to 13-week-old C57BL/6 mice
(Charles River) were used for cell puriﬁcation, analysis and cloning. Lines used for
ﬂow cytometry in conjunction with fate mapping are detailed in Supplementary
Table 3. For activation of Wt1-CreERT2 in utero, tamoxifen was given to gestating
females at E10.5 as a single dose of 0.04mg g 1 (1mg per mouse), reduced from
0.12mg g 1 (ref. 55) and with the addition of progesterone (1mg per mouse)16 to
improve embryo survival. For recombination in adult mice, tamoxifen was given at
8 weeks for 5 days consecutively (2mg per day per mouse). Tamoxifen and
progesterone were diluted in corn oil and administered by gavage.
Hearts were harvested, minced and enzymatically dissociated using
100mg.ml 1 Liberase TH Research grade and 50 mgml 1 DNAse I (Roche
Applied Science), with four to ﬁve cycles of digestion for a total maximum of
45min at 37 C. The resulting cardiomyocyte-depleted cell preparation was ﬁltered
through 70mm nylon mesh (BD Falcon). Hematopoietic lineage (Lin) depletion
and Sca1 enrichment were performed by immunomagnetic separation (AutoMACS
Pro Separator, Miltenyi Biotec). For Lin depletion, a cocktail of biotinylated
antibodies was used with super-paramagnetic microbeads (Miltenyi Biotec). For
Sca1 enrichment, cells were subsequently labelled with anti-Sca1-FITC antibody
and anti-FITC microbeads (Miltenyi Biotec), then puriﬁed by four cycles of
positive selection. In fate-mapping analyses, to minimize cell loss before ﬂow
sorting, no Sca1 enrichment was performed. To resolve SP and non-SP cells, cells
were stained with 5 mgml 1 Hoechst 33342 (Sigma-Aldrich) and ﬁltered as above.
Control samples for the dye-efﬂux assay included Hoechst 33342 with one or more
of the following inhibitors: 10 mM fumitremorgin C (Merck), 50 mm verapamil
(Sigma-Aldrich) or 5 mm reserpine (Sigma-Aldrich). The ﬁnal step comprised
staining with antigen-presenting cell (APC)-conjugated streptavidin (eBioscience),
to resolve any residual contaminating Linþ cells. Propidium iodide was added
as the routine dead cell marker. For fate-mapping analyses, TO-PRO3 was
used instead, for compatibility with the tdTom reporter; for cGATA5-Cre and
Mef2c-AHF-Cre, TO-PRO5 was used for additional compatibility with APC. Where
indicated, other minor modiﬁcations were made for speciﬁc experiments.
For isolation of neonatal mouse cardiomyocytes (1–3 days old), the hearts were
placed in Ca2þ - and Mg2þ -free phosphate-buffered saline containing 10 g l 1
D-glucose (PBS–Dg), washed 3 in PBS–Dg and minced to obtain fragments of
o1mm. This was followed by enzymatic dissociation in PBS–Dg containing 0.2%
collagenase type 2 (B50Umg 1), 0.05% DNAse (B3,200Umg 1) and 0.05%
Trypsin (B250Umg 1; #4179, #2009 and #3707, respectively; Worthington).
Digestion was performed for ﬁve rounds 10min each with agitation at 37 C. At
the end of each round, dissociation was facilitated by titruation and the dissociated
cell supernatant was transferred to D-MEM/F-12 media containing GlutaMAX,
50mgml 1 gentamicin (both, Invitrogen) and 10% fetal bovine serum (Hyclone).
The enzymatic solution was replaced with fresh solution for each round56. At the
end of the mechanical and enzymatic dissociation, myocytes were collected by
centrifugation, followed by Percoll puriﬁcation using 1.05, 1.06 and 1.82 gml 1
densities at 2,000g for 30min. The myocyte-enriched fraction (interface between
the 1.06 and 1.082 gml 1 layers) was harvested, washed and further enriched by
differential plating on standard tissue culture plates, upon which the cardiac
ﬁbroblasts adhere rapidly. After 45min, the myocyte-enriched suspension was
collected and redeposited onto Primaria tissue culture plates in D-MEM/F-12
containing 5% horse serum (Hyclone). Tail tip ﬁbroblasts were obtained by
mechanical and enzymatic dissociation, using 0.25% Trypsin–EDTA at 37 C for
30min with continuous rocking. PDGFRaþ Sca1þ CD45 TER119 bone
marrow MSCs were kindly provided by S. Rankin57.
The FACSAriaII ﬂow sorter and LSRII ﬂow cytometer (Becton Dickinson),
optimized for use in the Hoechst 33342 assay, were equipped identically with
355 nm ultraviolet, 405 nm violet, 488 nm blue, 561 nm yellow–green and 638 nm
red lasers. FlowJo vX was used for data analysis (versions 9.3.1 and 10.0.06;
Tree Star).
Cell cloning and robotic cell culture. Clones were generated by single-cell
deposition (FACSAriaII) into standard 96-well plates coated with 50 mgml 1
collagen type I (BD Bioscience). Where indicated, pools of 500–2,000 cells were
each seeded into a well of 96-well plates. Cells were cloned and propagated in
medium containing 35% Iscove’s Modiﬁed Dulbecco’s Medium, 32.5% Dulbecco’s
Modiﬁed Eagle’s Medium, 32.5% Ham’s F12 (all Invitrogen), 3.5% bovine growth
serum (Hyclone), 1.3% B27 supplement (Invitrogen), 6.5 ngml 1 recombinant
human epidermal growth factor, 13 ngml 1 recombinant human ﬁbroblast
growth factor-basic (154 a.a., Peprotech), 0.0005Uml 1 thrombin (Roche),
0.65 ngml 1 CT-1 (Cell Sciences), 2mM L-glutamine (Invitrogen),
1Antibiotic-Antimycotic (Invitrogen) and 0.14mM 2-mercaptoethanol
(Sigma-Aldrich)15. Clone formation was deﬁned as a colony Z1,500 mm in
diameter (usually4500 cells). Cells were trypsinized and expanded upon reaching
70–80% conﬂuency. Except where indicated, cells were maintained at 37 C in
ambient O2 (21%) and 5% CO2.
Following initial pilot studies done manually, clone generation and propagation
were performed using a customized Industrial Robot Integrated System (Beckman
Coulter), comprising two Cytomat24C cell culture incubators with capability for
hypoxic conditions (Thermo Fisher), compact HP 3JC Motoman robotic arm
(Yaskawa), Cytomat Microplate Hotel (Thermo Fisher), Biomek FXP liquid
handling system (Beckman Coulter), CloneSelect Imager (Molecular Devices) to
evaluate conﬂuency, Vi-CELL XR cell viability analyser (Beckman Coulter) for
trypan blue dye exclusion assays, and Bigneat enclosure. Secondary clones were
plated as above. Senescence-associated beta-galactosidase activity was determined,
using the Abcam Senescence Detection Kit.
Quantitative RT–PCR. mRNA was extracted manually using TRI reagent or
robotically using the Agencourt RNAdvance Tissue system and a Biomek FXP
liquid handler (Beckman). Samples were treated with TURBODNase (Applied
Biosystems) and RNA quantitated using a Nanodrop 8000 Spectrophotometer
(Thermo Fisher Scientiﬁc). Reverse transcription was performed with 0.25–1 mg of
RNA using the High Capacity cDNA kit (Applied Biosystems). qRT–PCR was
performed using TaqMan primer/probe sets (Supplementary Table 2), customized
TaqMan low-density array cards and an ABI PRISM 7900HT Sequence Detection
System (Applied Biosystems). Cycle number at threshold was calculated using RQ
Manager 1.2.1 (Applied Biosystems).
Data for TaqMan low-density array cards and single-cell qRT–PCR were
processed by the DCt method58, in the R/Bioconductor platform (version 2.15.2)
using custom R code. The heatmaps and density plots were visualized using the
gplots (CRAN repository) and beanplot packages, respectively.
For the analyses of cardiac SP clones in comparison to a selection of reference
tissues (Fig. 3, Supplementary Fig. 2), the expression of 40 test genes was measured
together with 3 ubiquitous normalization controls (18 S, Hmbs and Ubc) for each
sample. A total of 20 independent clonal cardiac SP lines was investigated, at
varying passage number o30 (40 groups) and including replicated samples (for a
total number of 87). The expression of each sample was normalized to the
combined expression (geometric mean) of the two most stable reference genes
(Hmbs and Ubc) to obtain the normalized value of DCt59.
The correlation between the cardiac SP clones and reference tissues was
evaluated by calculating the Pearson correlation (r) for all sample pairs from the
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DCt values for all 40 test genes for each sample. Results were then arranged by
hierarchical clustering and visualized as a heatmap (Fig. 3a). The Pearson
correlation (r) can extend from  1 to 1. A value close to 1 indicates a high positive
correlation (all genes expressed similarly between the two samples), close to 0
(blue) a weak correlation and close to  1 an anti-correlated gene expression
proﬁle.
The molecular signature of the cardiac SP clones is shown as bar plots on a
linear scale (2DCt) in Fig. 3b, which shows the mean expression of all 40
measured genes in the 20 clones. The genes were grouped and colour coded on the
basis of functional association and tissue speciﬁcity. The nparcomp R package was
used to perform nonparametric multiple comparisons based on relative contrasts
effects. Dunnett’s contrasts were speciﬁed, where each reference tissue is compared
with the cloned SP samples (Supplementary Fig. 2). The statistic was then
computed using multivariate transformation (Probit transformation function).
To elucidate the expression proﬁle of key cardiac transcription factors across
the single cardiac SP clones, inverted DCt values for each gene were visualized in a
density plot (Fig. 3c). To estimate the population density of expression for each
gene, we used a Gaussian kernel density estimation procedure applied to each of
the 20 SP clones (short vertical lines). Again, the genes were ordered using
hierarchical clustering. During this process, the expression of cardiogenic
transcription factors within each sample was ﬁrst scaled by their mean and s.d. This
results in a Z-score, with zero mean and unit variance, which normalizes the
sample-speciﬁc variability. Subsequently, the clustering algorithm was applied
to separate genes with heterogeneous (multimodal) expression (Gata4, Mef2c,
Tbx5 and Hand2) from genes with homogeneous low/negative expression
(Isl1, Hand1and Nkx2-5) and homogeneous high expression (Tbx20, Tbx2, Mef2a
and Gata6).
Single-cell qRT–PCR. Single cells were sorted directly (FACSAria II) into 96-well
plates containing 10 ml of the reaction mixture for pre-ampliﬁcation, using
CellDirect One-Step qRT–PCR Kits (Invitrogen). Pre-ampliﬁcation was performed
in a Veriti Thermal Cycler (Applied Biosystems) for 22 cycles. As negative
controls, at least 3–5 non-template samples were included in each run at the
pre-ampliﬁcation stage. Quantitative ampliﬁcation was performed using Dynamic
Array chips for 48 assays 48 samples, the BioMark HD system (Fluidigm) and
TaqMan primer/probe sets as above. The stability of endogenous controls was
estimated59 and each sample was consequently normalized to DCt using the
expression of Ubc. Samples were centred around their individual means by
subtracting the mean expression of all the genes within the sample. This results in a
standardized gene expression with zero mean in each sample, thus correcting the
technical error associated with batch acquisition.
To visualize the expression of key genes in the populations tested, data were
plotted in colour-coded heatmaps of inverted DCt values (Figs 1 and 8): blue (gene
expression low/none) to red (high). Samples were ordered on the basis of cell type,
and the genes grouped by a hierarchical clustering algorithm according to the
underlying co-expression pattern (Fig. 1) or variance between the sample classes
(Fig. 8). Individual gene expression levels between selected samples were compared
using density plots. To identify differential expression, the genes were classiﬁed as
present or absent using a Gaussian mixture model classiﬁcation procedure. The
frequency distribution of each gene was then calculated from the combination of
two sample classes: SP versus non-SP (Fig. 1) or PDGFRaþ /CD31 versus
PDGFRa /CD31þ (within SP, non-SP and Sca1þ groups; Fig. 8). The level of
signiﬁcance was obtained with Fisher’s Exact test and the resulting P-values
adjusted using the Bonferroni correction.
Differences between samples were investigated using PCA60. PCA applies
multiple linear transformations (singular value decomposition) to the expression
proﬁles (standardized DCt values) of individual samples and identiﬁes a series of
PCs that elucidate the most distinguishing features between the samples. The linear
projections (PC scores) attempt to maximize the variation between the samples,
whereas the coefﬁcients of those projections (PC loadings) measure the importance
of genes in deﬁning the underlying variability associated with each component.
Western blotting. For western blotting, cells and tissues were lysed for 45min at
4 C in radioimmunoprecipitation assay (RIPA) buffer (Sigma-Aldrich), with the
addition of cOmplete, EDTA-free, Protease Inhibitor Cocktail and PhosSTOP
Phosphatase Inhibitor Cocktail tablets (Roche). Nuclear and cytoplasmic lysates
was isolated using Nuclear/Cytosol Fractionation kits (Biovision). Proteins were
quantitated by the Pierce BCA assay kit (Thermo Fisher). Lysates were size-
fractionated by SDS–polyacrylamide gel electrophoresis (mg per lane), transferred
to Hybond ECL nitrocellulose membranes (GE Healthcare), probed with the
indicated antibodies and analysed by enhanced chemiluminescence (GE Health-
care). Glyceraldehyde 3-phosphate dehydrogenase and histone H1 were used,
respectively, to authenticate the purity of cytoplasmic and nuclear lysates.
For a full view of the blots including the location of molecular weight markers,
see Supplementary Fig. 3.
Immunocytochemistry. Cultured cells were ﬁxed in 4% paraformaldehyde in PBS
for 15min then treated for 1 h with blocking buffer containing 4% fetal bovine
serum albumin (Sigma-Aldrich) and 0.2% Triton X-100 (VWR) in PBS. Cells were
incubated with primary antibodies overnight at 4 C in blocking buffer, washed
(3 5min), and incubated with species-speciﬁc secondary antibodies for 1 h at
room temperature. Species-speciﬁc isotype controls were used for all primary
antibodies. Cells were counterstained with 4 mgml 1 Hoechst 33342 or 4 mgml 1
40, 6-diamidino-2-phenylindole (DAPI) for 2min to visualize nuclei. Image
acquisition was performed on an Axio Observer Z1 inverted epiﬂuoresence
microscope at 20magniﬁcation using AxioVision v 4.8 (Zeiss).
Immunohistochemistry. For tissue staining, 10mm sections were blocked with
normal serum (Vector) for 30min before incubation with antibodies. For the
12-week-time-point hearts, which were parafﬁn embedded, sections were
deparafﬁnized in xylene, rehydrated through ethanol and antigens were retrieved
with citrate buffer (pH 6.0, 1.92mgml 1 citric acid) in a microwave. Primary
antibodies were incubated for 1 h at room temperature or overnight at 4 C and
secondary antibodies for 1 h at room temperature. Sections were mounted in
Prolong Gold with DAPI (Invitrogen). Routine imaging and quantiﬁcation were
performed on a Zeiss Axio Observer Z1 wideﬁeld ﬂuorescent microscope and
confocal imaging with a Leica SP5 or Zeiss LSM-780 microscope. For each com-
bination of donor cell and antibody tested, 200 mOrange-positive donor cells
were counted, encompassing at least ﬁve ﬁelds at 400magniﬁcation, and the
expression of cardiomyocyte, endothelial and SM markers was scored manually by
two independent observers blinded to the conditions. Two-way analysis of variance
with Bonferonni post-hoc tests was used for statistical analysis, with Po0.05 as the
threshold for signiﬁcant results.
For details and concentrations of the antibodies used, see Supplementary
Table 1.
Cardiac injury and cell grafting. Cells were transduced in the presence of
hexadimethrine bromide (Polybrene, Sigma-Aldrich) with a modiﬁed version of
the lentiviral vector pLL3.7 (ref. 61), replacing the CMV promoter with the
phosphoglycerate kinase promoter and the green ﬂuorescent protein reporter with
mOrange. Successfully transduced cells were identiﬁed and fractionated by
preparative ﬂow sorting. For all four clones investigated, the resulting purity of
mOrangeþ cells was 497%.
For coronary artery ligation62,63, C57BL/six females aged 10–14 weeks were
anesthetized with 2% isoﬂuorane and given buprenorphine (0.05mg kg 1) for
analgesia. The trachea was intubated for mechanical ventilation (120 strokes per
min, 200 ml stroke volume, Harvard Apparatus). The thorax was opened at the left
fourth intercostal space and the proximal left coronary artery was ligated with 8-0
Ethilon suture (Ethicon). Sham-operated animals were treated similarly but did not
have the ligature tied. Immediately after infarction, mice received two intramural
injections into the infarct border zone using a 30 gauge Hamilton syringe, each
with 250,000 mOrange-labelled cells in 10 ml saline (Hamelyn Pharmaceuticals).
Control mice were injected with saline alone. The chest was closed with 5-0 Mersilk
suture (Ethicon).
For histological analysis, mice were euthanized by cervical dislocation 1, 14 days
and after surgery and perfusion-ﬁxed with PBS followed by 4% paraformaldehyde
in PBS. The hearts were then removed, bisected longitudinally, ﬁxed in 4%
paraformaldehyde for 6 h at 4 C, then placed in 10% sucrose in distilled water
overnight. Hearts were embedded in optimal cutting temperature compound
(Sakura) and frozen in liquid nitrogen-cooled isopentane. For immunostaining,
10 mm frozen sections were prepared using a Leica cryostat (Leica Microsystems).
For the 12-week time point, hearts were parafﬁn embedded to improve tissue
preservation.
Re-isolation of donor-derived cells. To isolate donor-derived cardiomyocytes
(Fig. 4c), grafted hearts ﬁrst were subjected to retrograde Langendorff perfusion for
5min with high-calcium Krebs solution pre-oxygenated with 95% O2, 5% CO2
containing (mM) 119 NaCl, 4.7 KCl, 0.94 MgSO4, 1.2 KH2PO4, 25 sodium
bicarbonate, 11.5 glucose, 5 nitrilotriacetic acid, 1 Ca2þ , pH 6.95 (ref. 64).
Subsequently, 5min of perfusion was performed with a low-calcium solution
containing 50 mM Ca2þ and 10 mM 2, 3-butanedione monoxime (BDM, Sigma),
pH 6.95. Next, the hearts were subjected to enzymatic digestion by recirculation
perfusion for 2min with low-calcium Krebs solution supplemented with Protease
type XXIV (0.182mgml 1, Sigma), 10mM BDM, pH 7.4, followed by perfusion
with low-calcium solution containing 1mgml 1 collagenase (Worthington),
0.6mgml 1 hyaluronidase (Sigma), 10mM BDM, pH 7.4 (ref. 64). Tissue was
then minced and agitated under 100% O2 in collagenase for 5–15min, until
digestion of the ventricles was complete. The cell suspension was then centrifuged
at low speed and the pellet suspended in low-Ca2þ Krebs solution64.
A modiﬁed protocol was used to analyse a-sarcomeric actin expression in
donor-derived cardiomyocytes by immunoﬂuorescence and better preserve their
sarcomeric structure (Fig. 4d). Retrograde perfusion was performed in Ca2þ -free
buffer, a recombinant enzyme mix was used (Liberase; Roche), Ca2þ
re-introduction was performed at room temperature and cells were plated
on dishes coated with 2mgml 1 laminin (Invitrogen).
Fate mapping. A Cre-lox system was used for fate mapping (see Supplementary
Table 3 for the lines used). Typically, F1 double transgenic mice were generated by
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crossing Cre deleter males with R26R-tdTom females, to prevent ectopic reporter
expression caused by nonspeciﬁc deletion of ﬂoxed alleles65. Due to the reported
‘parent-of-origin’ effect66, female EIIa-Cre mice were crossed with R26R-tdTom
males. Because inconsistent recombination even between littermates was reported
for several of the Cre strains used (Tek-Cre, Vav-Cre67), multiple bigenic specimens
from at least two independent litters were analysed for all crosses, to avoid possible
misinterpretation caused by sample variation, and samples with anomalous
reporter activity were excluded from further analysis.
Magnetic resonance imaging. Mice were imaged using a 9.4 T MRI system
(Agilent, Palo Alto, CA, USA) and a 38mm quadrature-driven birdcage RF coil
(Rapid Biomedical, Rimpar, Germany). Multi-slice cardiac and respiratory gated
cine-MRI was performed in the true short-axis orientation and covered the whole
LV68. Late gadolinium-enhanced MRI was performed 20min after intraperitoneal
(i.p.) injection of 0.5mmol kg 1 Gd-DTPA-BMA (Omniscan, GE Healthcare,
Hatﬁeld, UK), using a multi-slice inversion recovery sequence69. Data were
analysed in a blinded fashion using ImageJ (NIH, Bethesda, MD, US). Standard
measures of left and right ventricular morphology and function were made from
cine stacks, and infarct area determined by thresholding to three s.d. above the
mean remote myocardial signal intensity70. Infarct size was quantiﬁed as epicardial
circumferential length of the enhanced tissue, expressed as a percentage of total
epicardial circumference of the left ventricle.
Statistics. The statistical approaches to RNA proﬁling are given in the sections on
qRT–PCR above. For other experimental procedures, unless otherwise stated,
Student’s two-tailed t-test was used for pairwise comparisons and one-way (Fig. 6)
or two-way analysis of variance with Bonferroni’s correction for multiple
comparisons.
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